-
President of Medicine & Science calls for unifying biomedical science and social determinants of care
A. Enrique Caballero, MD, highlighted the progress advancing diabetes treatment and management while shedding light on existing gaps in care and advocating for integrating advances in science into the real-world context in which people live.
-
Banting Medalist encourages embracing the unexpected to drive medical innovation
In his award lecture, Takashi Kadowaki, MD, PhD, explained how contradictions between hypotheses and results have enabled him to achieve major breakthroughs in understanding type 2 diabetes.
Scientific Sessions Newsmakers
-
Discussion to consider pragmatic solutions through diabetes technology across diverse demographics and settings
Michelle Litchman, PhD, APRN, FNP-BC, and other experts will examine data, challenges, and best practices around the use of continuous glucose monitoring (CGM) and automated insulin delivery (AID) devices among children, older adults, the Deaf community, and inpatient populations.
-
Joint ADA/IDF symposium to address malnutrition-related diabetes diagnosis, treatment, and research needs
Peter E. H. Schwarz, MD, PhD, MBA, and other leading experts from across the globe will discuss the latest information on the prevention, diagnosis, and treatment of what an international working group has designated as type 5 or malnutrition-related diabetes.
-
Panel to offer strategies for supporting psychological wellbeing for women and girls with diabetes
Paige Trojanowski, PhD, and other panelists will present the latest findings on unique diabetes challenges during female adolescence, pregnancy, postpartum, parenting, menopause, and hormone replacement therapy.
-
Positive data from multiple amylin trials draw focus to novel therapeutic mechanism
Investigators, including Carel le Roux, MBChB, FRCP, FRCPath, PhD, discussed findings from monotherapy and combination trials with the pancreatic beta cell hormone. “Not only are these weight loss drugs, these are also health-gain drugs,” Dr. le Roux said.
-
Ultra-long-acting GLP-1 RA improves weight loss in individuals with and without type 2 diabetes
A Scientific Sessions panel shared new data from the VESPER trials. The long half-life of berobenatide makes investigators optimistic about its potential for monthly dosing.
-
Year in Review symposium to deliver the latest discoveries in diabetes
Anne Peters, MD, will highlight major advances and discoveries in the clinical science of diabetes, including expanding treatment and technology options. Raghu Mirmira, MD, PhD, will summarize translational progress, and Barbara Kahn, MD, will share basic science developments.
Presenter Profiles